These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 9626068)
1. Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis. Stevenson DP; Milligan SR; Collins WP Am J Pathol; 1998 Jun; 152(6):1641-6. PubMed ID: 9626068 [TBL] [Abstract][Full Text] [Related]
2. Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose. Uchimiya H; Furukawa T; Okamoto M; Nakajima Y; Matsushita S; Ikeda R; Gotanda T; Haraguchi M; Sumizawa T; Ono M; Kuwano M; Kanzaki T; Akiyama S Cancer Res; 2002 May; 62(10):2834-9. PubMed ID: 12019161 [TBL] [Abstract][Full Text] [Related]
3. Thymidine phosphorylase activity and prodrug effects in a three-dimensional model of angiogenesis: implications for the treatment of ovarian cancer. Stevenson DP; Collins WP; Farzaneh F; Hata K; Miyazaki K Am J Pathol; 1998 Nov; 153(5):1573-8. PubMed ID: 9811349 [TBL] [Abstract][Full Text] [Related]
4. Expression of thymidine phosphorylase correlates with microvessel density in prostate cancer. Kataoka A; Yuasa T; Kageyama S; Iwaki H; Higuchi K; Tanaka T; Okada Y; Yoshiki T Oncol Rep; 2005 Apr; 13(4):597-600. PubMed ID: 15756429 [TBL] [Abstract][Full Text] [Related]
5. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. Fox SB; Moghaddam A; Westwood M; Turley H; Bicknell R; Gatter KC; Harris AL J Pathol; 1995 Jun; 176(2):183-90. PubMed ID: 7636628 [TBL] [Abstract][Full Text] [Related]
6. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo. Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660 [TBL] [Abstract][Full Text] [Related]
7. The role of vascular endothelial growth factor-A (VEGF-A) and platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) in Paget's disease of the vulva and breast. Ellis PE; Wong Te Fong LF; Rolfe KJ; Crow JC; Reid WM; Davidson T; MacLean AB; Perret CW Anticancer Res; 2002; 22(2A):857-61. PubMed ID: 12014662 [TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Toi M; Inada K; Hoshina S; Suzuki H; Kondo S; Tominaga T Clin Cancer Res; 1995 Sep; 1(9):961-4. PubMed ID: 9816067 [TBL] [Abstract][Full Text] [Related]
15. Influence of platelet-derived endothelial cell growth factor/thymidine phosphorylase on the cell cycle in head and neck squamous cell carcinoma in vitro. Igawa H; Fujieda S; Kimura Y; Sugimoto C; Tanaka N; Ohtsubo T; Kato Y; Saito H Oncol Rep; 2003; 10(4):967-71. PubMed ID: 12792754 [TBL] [Abstract][Full Text] [Related]
16. Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase. Miyadera K; Sumizawa T; Haraguchi M; Yoshida H; Konstanty W; Yamada Y; Akiyama S Cancer Res; 1995 Apr; 55(8):1687-90. PubMed ID: 7536129 [TBL] [Abstract][Full Text] [Related]
17. Interrelationship of platelet-derived endothelial cell growth factor, liver macrophages, and tumor microvessel density in patients with cholangiocellular carcinoma. Miwa S; Soeda J; Miyagawa S Hepatogastroenterology; 2005; 52(65):1398-402. PubMed ID: 16201082 [TBL] [Abstract][Full Text] [Related]
18. The role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in tumor behavior. Bijnsdorp IV; de Bruin M; Laan AC; Fukushima M; Peters GJ Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):681-91. PubMed ID: 18600526 [TBL] [Abstract][Full Text] [Related]